Literature DB >> 11181538

Targeted protein kinase A and PP-2B regulate insulin secretion through reversible phosphorylation.

L B Lester1, M C Faux, J B Nauert, J D Scott.   

Abstract

Protein kinases and phosphatases play key roles in integrating signals from various insulin secretagogues. In this study, we show that the activities of the cAMP-dependent protein kinase (PKA) and the calcium/calmodulin-dependent phosphatase, PP-2B are coordinated resulting in the regulation of insulin secretion. Transient inhibition of PP-2B, using the immunosuppressant FK506, increased forskolin stimulated insulin secretion by 2.5-fold +/- 0.3 (n = 6) in rat islets and RINm5F cells. Surprisingly, forskolin treatment resulted in the dephosphorylation of the vesicle-associated protein synapsin 1 and increased PP-2B activity by 2.98 +/- 0.97-fold (n = 4). One potential explanation for the observed coordination of PKA and PP-2B activity is their colocalization through a mutual anchoring protein, AKAP79/150. Accordingly, RINm5F cells expressing AKAP79 exhibited decreased insulin secretion, reduced PP-2B activity and were insensitive to FK506. This suggests that AKAP targeting of PKA and PP-2B maintains a signal transduction complex that may regulate reversible phosphorylation events involved in insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181538     DOI: 10.1210/endo.142.3.8023

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

Review 1.  The role of serine/threonine protein phosphatases in exocytosis.

Authors:  Alistair T R Sim; Monique L Baldwin; John A P Rostas; Jeff Holst; Russell I Ludowyke
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 2.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Acute rejection modulates gene expression in the collecting duct.

Authors:  Bayram Edemir; Stefan Reuter; Reka Borgulya; Rita Schröter; Ute Neugebauer; Gert Gabriëls; Eberhard Schlatter
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

4.  Snapin mediates incretin action and augments glucose-dependent insulin secretion.

Authors:  Woo-Jin Song; Madhav Seshadri; Uzair Ashraf; Thembi Mdluli; Prosenjit Mondal; Meg Keil; Monalisa Azevedo; Lawrence S Kirschner; Constantine A Stratakis; Mehboob A Hussain
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

5.  Setting sail for glucose homeostasis with the AKAP150-PP2B-anchor.

Authors:  Adrian Kee Keong Teo; Rohit N Kulkarni
Journal:  EMBO J       Date:  2012-09-14       Impact factor: 11.598

Review 6.  Bigger, better, faster: principles and models of AKAP anchoring protein signaling.

Authors:  Eric C Greenwald; Jeffrey J Saucerman
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

7.  Differential mechanisms of adenosine- and ATPγS-induced microvascular endothelial barrier strengthening.

Authors:  Róbert Bátori; Sanjiv Kumar; Zsuzsanna Bordán; Mary Cherian-Shaw; Anita Kovács-Kása; Justin A MacDonald; David J R Fulton; Ferenc Erdődi; Alexander D Verin
Journal:  J Cell Physiol       Date:  2018-12-17       Impact factor: 6.384

Review 8.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

9.  MyRIP anchors protein kinase A to the exocyst complex.

Authors:  April S Goehring; Benjamin S Pedroja; Simon A Hinke; Lorene K Langeberg; John D Scott
Journal:  J Biol Chem       Date:  2007-09-07       Impact factor: 5.157

Review 10.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity.

Authors:  Alban Latremoliere; Clifford J Woolf
Journal:  J Pain       Date:  2009-09       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.